Ignite Creation Date:
2025-12-24 @ 5:01 PM
Ignite Modification Date:
2026-01-04 @ 6:21 AM
Study NCT ID:
NCT03207750
Status:
COMPLETED
Last Update Posted:
2020-12-29
First Post:
2017-06-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-14
Start Date Type:
ACTUAL
Primary Completion Date:
2018-10-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-03-01
Completion Date Type:
ACTUAL
First Submit Date:
2017-06-16
First Submit QC Date:
None
Study First Post Date:
2017-07-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2019-10-08
Results First Submit QC Date:
None
Results First Post Date:
2019-10-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-07
Last Update Post Date:
2020-12-29
Last Update Post Date Type:
ACTUAL